| Politicians, regulatory authorities, and collaboration with industry. | 内分泌
> 生长障碍 | 监管合作伙伴关系
> 与监管机构合作 | 1,000 | National | Regularly | 119027172028 |
| We are represented on the patient council of the NT/MTP-rådet [rådet för nya terapier/medicintekniska produkter – New Therapies/Medical Technology Products Council]. | 内分泌
> 甲状腺疾病 | 监管合作伙伴关系
> 与监管机构合作 | 100,000 | National | Sometimes | 119035997555 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], NT-rådet [Nya terapier-rådet – New Therapies Council], LV [Läkemedelsverket – Medical Products Agency], Socialstyrelsen [National Board of Health and Welfare], etc. | 心理健康
> 精神分裂症 | 监管合作伙伴关系
> 与监管机构合作 | 5,000 | National | Regularly | 119054525537 |
| We sit on the patient council of TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] contributed to the expert group for the principal responsibility inquiry (huvudmannaskapsutredningen), and serve on working groups for various national clinical guidelines, among other activities. | 风湿性
> 风湿性疾病：大多数类型 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100,000 | National | Regularly | 119012976039 |
| We participate in TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] assessments relating to bleeding disorders. | 出血
> 出血性疾病：大多数类型 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100 | National | Regularly | 119013112468 |
| Meetings with companies prior to reimbursement applications. | 内分泌
> 生长障碍 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 1,000 | National | Regularly | 119027170967 |
| Meetings with companies prior to reimbursement applications. Meetings with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] to improve the process at a national level. Meetings with policymakers for the same purpose. | 内分泌
> 生长障碍 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 1,000 | National | Regularly | 119027170967 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency]. | 心理健康
> 精神分裂症 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 1,000 | National | Sometimes | 119035155217 |
| We participate in the patient council of the NT/MTP Council [NT-rådet (Rådet för nya terapier)/MTP-rådet (Medicintekniska produktrådet) - the Swedish national body issuing recommendations on new therapies and medicinal products]. In individual cases, we have been in contact with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] ahead of pricing decisions for medicines. | 内分泌
> 甲状腺疾病 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100,000 | National | Sometimes | 119035997555 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], NT-rådet [Nya terapier-rådet – New Therapies Council], LV [Läkemedelsverket – Medical Products Agency], Socialstyrelsen [National Board of Health and Welfare], etc. | 心理健康
> 精神分裂症 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 5,000 | National | Regularly | 119054525537 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], for example. | 癌症
> 癌症：大多数类型 | 监管合作伙伴关系
> 参与卫生技术评估（HTA）和报销审查 | 100,000 | National | Regularly | 119054604148 |
| EMA [European Medicines Agency]. | 肝脏
> 肝炎 | 监管合作伙伴关系
> 为营销授权申报做出贡献 | 1,000 | National | Regularly | 119036786869 |
| We sit on the patient council of TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] contributed to the expert group for the principal responsibility inquiry (huvudmannaskapsutredningen - looking at municipal versus national healthcare responsbilities), and serve on working groups for various national clinical guidelines, among other activities. | 风湿性
> 风湿性疾病：大多数类型 | 监管合作伙伴关系
> 参与临床指南制定机构 | 100,000 | National | Regularly | 119012976039 |
| Collaboration with the medicines committee. | 骨骼
> 骨质疏松症 | 监管合作伙伴关系
> 参与临床指南制定机构 | 10,000 | National | Sometimes | 119012989318 |
| We have participated in the development of national clinical guidelines. | 神经系统
> 偏头痛 | 监管合作伙伴关系
> 参与临床指南制定机构 | 100 | National | Sometimes | 119021956027 |
| Politicians, regulatory authorities, and collaboration with industry. | 内分泌
> 生长障碍 | 监管合作伙伴关系
> 参加/主持与政策制定者/监管机构的会议 | 1,000 | National | Regularly | 119027172028 |
| Through EAPN [European Anti-Poverty Network] in the Riksdag [Swedish Parliament]. | 心理健康
> 心理健康：大多数状况 | 监管合作伙伴关系
> 与其他医疗保健倡导者 | 1,000 | Local | Rarely | 119012977988 |
| Meetings with companies prior to reimbursement applications. Meetings with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] to improve the process at a national level. Meetings with policymakers for the same purpose. | 内分泌
> 生长障碍 | 影响政策和立法
> 影响医疗保健政策和立法 | 1,000 | National | Regularly | 119027170967 |
| Primarily in political contexts, through advisory councils and similar bodies, in response to political indifference. | 心理健康
> 心理健康：大多数状况 | 影响政策和立法
> 影响医疗保健政策和立法 | 100 | Local | Regularly | 119054580960 |
| We have met with regional politicians and provided information about the disease. | 癌症
> 癌症：前列腺 | 影响政策和立法
> 动员议员和政治领导人 | 1,000 | Regional | Sometimes | 119014676970 |
| We participate in the patient council of the NT/MTP Council [NT-rådet (Rådet för nya terapier)/MTP-rådet (Medicintekniska produktrådet) - the Swedish national body issuing recommendations on new therapies and medicinal products]. In individual cases, we have been in contact with TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] ahead of pricing decisions for medicines. | 内分泌
> 甲状腺疾病 | 定价与可负担性倡导
> 参与价格审查委员会谈判 | 100,000 | National | Sometimes | 119035997555 |
| We have previously been involved when a specific dressing was replaced with something “equivalent.” If contacting the hospital does not help, we have sometimes taken it further with the support of the company whose dressing we are trying to obtain. | 稀有
> 罕见病：EB | 定价与可负担性倡导
> 监控产品替换 | 1,000 | National | Rarely | 119062893384 |
| We have previously been involved when a specific dressing was replaced with something “equivalent.” If contacting the hospital does not help, we have sometimes taken it further with the support of the company whose dressing we are trying to obtain. | 稀有
> 罕见病：EB | 诊断与药品配送
> 确保安全有效地使用药物 | 1,000 | National | Rarely | 119062893384 |
| We have participated in the development of national clinical guidelines. | 神经系统
> 偏头痛 | 诊断与药品配送
> 参与制定临床指南 | 100 | National | Sometimes | 119021956027 |
| We sit on the patient council of TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency] contributed to the expert group for the principal responsibility inquiry (huvudmannaskapsutredningen), and serve on working groups for various national clinical guidelines, among other activities. | 风湿性
> 风湿性疾病：大多数类型 | 机构治理
> 确保在政府咨询机构中的代表性 | 100,000 | National | Regularly | 119012976039 |
| We have a dedicated advocacy representative who monitors developments and safeguards our interests. | 心理健康
> 心理健康：大多数状况 | 机构治理
> 确保在政府咨询机构中的代表性 | 100 | Local | Rarely | 119022071652 |
| We are represented on the patient council of the NT/MTP-rådet [rådet för nya terapier/medicintekniska produkter – New Therapies/Medical Technology Products Council]. | 内分泌
> 甲状腺疾病 | 机构治理
> 确保在政府咨询机构中的代表性 | 100,000 | National | Sometimes | 119035997555 |
| TLV [Tandvårds- och läkemedelsförmånsverket – Dental and Pharmaceutical Benefits Agency], NT-rådet [Nya terapier-rådet – New Therapies Council], LV [Läkemedelsverket – Medical Products Agency], Socialstyrelsen [National Board of Health and Welfare], etc. | 心理健康
> 精神分裂症 | 机构治理
> 确保在政府咨询机构中的代表性 | 5,000 | National | Regularly | 119054525537 |
| Primarily in political contexts, through advisory councils and similar bodies, in response to political indifference. | 心理健康
> 心理健康：大多数状况 | 机构治理
> 确保在政府咨询机构中的代表性 | 100 | Local | Regularly | 119054580960 |
互动
行动与倡导
16 提及
